Lung Cancer Screening Software Market Size, Share & Trends Analysis Report By Region (North America (U.S., Canada, Mexico), APAC, Europe, Latin America, MEA), And Segment Forecasts, 2024 - 2030

Lung Cancer Screening Software Market Size, Share & Trends Analysis Report By Region (North America (U.S., Canada, Mexico), APAC, Europe, Latin America, MEA), And Segment Forecasts, 2024 - 2030

Lung Cancer Screening Software Market Growth & Trends

The global lung cancer screening software market size is expected to reach USD 45.0 million by 2030, registering a CAGR of 6.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing incidence of lung cancer and rise in implementation of lung cancer screening programs across the globe are some of the significant factors driving the market growth. According to Globocan estimates, about 160,068 new cases of lung cancer were reported in South East Asian region in 2018.

A number of clinical trials, studies, and demonstration projects are being conducted around the world to evaluate the effectiveness of lung cancer screening programs. For instance, in 2017, Cancer Care Ontario launched a screening pilot trial for people at high risk. Favorable government initiatives for successful implementation of such programs and increasing awareness about the disease screening are also likely to contribute to the market growth in the coming years.

Lung cancer screening programs are widely adopted by hospitals and radiological centers in U.S. However, they are usually performed as a part of national or provisional screening program outside the country. In case of Latin America and Middle Eastern countries, limited availability of resources, restricted funding, low awareness levels, and lack of trained personnel are some of the factors that impede market growth.

Lung Cancer Screening Software Market Report Highlights

• In 2023, North America accounted for the highest revenue share owing to various lung cancer screening programs and favorable reimbursement scenario in the region
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period
• This is attributed to the increasing cases of lung cancer and rise in the number of screening trials & studies for the disease

Please note The report will be delivered in 2-3 business days upon order notification.